ABcann Global Corporation (TSXV:ABCN) (the “Company”) is pleased to announce the appointment of W. Brett Wilson to the Advisory Board of the Company in connection with the completion of the Company’s acquisition of ABcann Medicinals Inc. (the “Transaction”). The Transaction included concurrent capital raises of $26.8 million to expand ABcann’s production capacity.

Mr. Wilson’s extensive experience and track record in financing and building early stage ventures into successful companies makes him an ideal strategic advisor to the Company at this stage of its development. Mr. Wilson was a co-founder in 1993 of the highly regarded investment bank, FirstEnergy (which was subsequently acquired by GMP Capital Inc.). He is a leading TV personality, known for his role as a “Dragon” on CBC’s award winning Dragons’ Den television program, and an early-stage venture financier in hundreds of successful companies.


Mr. Wilson’s involvement and $500,000 investment in the Company’s subscription receipt offering undertaken concurrently with the completion of the Transaction represents another major step for Mr. Wilson into the legal cannabis industry. He is also a lead investor and strategic advisor with Green Acre Capital, a Toronto and Calgary based cannabis industry focused investment fund.

“Mr. Wilson is a welcome addition to the Company’s Advisory Board. He’s a widely respected, established, and accomplished business leader and will complement the talents of our directors and advisors. We look forward to utilizing Brett’s knowledge and experiences as we grow the ABcann brand and welcome his personal investment and interest into the Company,” says Aaron Keay, CEO and a director of the Company.

ON BEHALF OF THE BOARD OF DIRECTORS

“Aaron Keay”
Aaron Keay
CEO and Director

For further information, please contact Aaron Keay by phone at (604) 323-6911 or by email aaron@abcannglobal.com OR Leo Karabelas by phone at 416 543-3120 or by email leo.k@abcannglobal.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Disclaimer for Forward-Looking Information

Certain statements in this release are forward-looking statements, which are statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include statements relating to the timing of the resumption of trading of the Company’s shares on the TSXV and the expected contributions of Mr. Wilson. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including that delays may occur in timing of the resumption of trading and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors, and the more extensive risk factors included in the filing statement filed by the Company in connection with the Transaction, carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.

Click here to connect with ABcann Global (TSX-V:ABCN) to receive an Investor Presentation.

Source: globenewswire.com

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading U.S. provider of consumer products in cannabis, today announced the Company will have senior management participating in the following virtual financial community conferences and events during December 2020 .

  • Roth Deer Valley Consumer Conference – December 9 th to 11 th , 2020
  • Cantor Fitzgerald 2020 Virtual Cannabis MSO Summit – December 15 th to 16 th , 2020
  • MKM Partners – The Road Ahead, Preparation for 2021 Conference – December 15 th to 16 th , 2020

For more information regarding upcoming Curaleaf financial community conference and event participation please visit the investor relations section of the company website, under the events tab, at https://ir.curaleaf.com/events .

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the appointment of Dr. Joel Moody, MD, MPH, DTM&H, as a medical and clinical advisor to the Company to assist in the expansion of clinical studies in Canada and the clinical data analysis on the ongoing U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.

“We would like to welcome Dr. Moody as a medical and clinical advisor to our team and we look forward to his contributions in our ongoing FDA Phase 3 clinical study as well as expanding our COVID-19 studies in Canada,” said Michael Frank, CEO of Revive. “Dr. Moody’s experience in clinical epidemiology, data analysis and research are key to our FDA Phase 3 study as we gather clinical data from patients enrolled.”

Keep reading... Show less

– FinCanna Capital Corp. (CSE:CALI) (OTCQB:FNNZF), based in Vancouver, BC today announced that Andriyko Herchak, CEO, will present live at VirtualInvestorConferences.com on December 3 rd .

Keep reading... Show less

First-of-its-kind trial in Canada will pave the way for expanded MDMA-assisted treatment to support patients with posttraumatic stress disorder

Keep reading... Show less

Multi-year partnership designates BioSteel as new official sports drink of Philadelphia 76ers team, Training Complex, and the presenting partner of 76ers Training Camp

BioSteel today announced a multi-year deal with the Philadelphia 76ers, making the sports hydration company the official sports drink of the team. BioSteel will also serve as a partner of the Philadelphia 76ers Training Complex, and the presenting partner for 76ers Training Camp, which begins next week.

Keep reading... Show less